1, High levels of IGF1 and insulin in obesity downregulate GSK3B activity by phosphorylating its serine residue, upregulation CXCL1, CCL20, and IL-6 expression (84)1、 2, Tumor antigens deficiency (95). The gene discussed is GSK3B; the disease is obesity disorder.